
Opinion|Videos|April 7, 2025
How the Genetic Nature of Lp(a) Levels Influences Screening
Experts discuss the genetic determinants of lipoprotein(a) (Lp[a]) levels, providing evidence supporting this conclusion. They also explore how the hereditary nature of Lp(a) can drive awareness of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis risk, potentially influencing screening protocols.
Advertisement
Video content above is prompted by the following:
- I mentioned in the introduction that a person’s Lp(a) levels are mostly determined by genetics. What evidence supports this conclusion?
- How might the hereditary nature of Lp(a) help drive awareness of risk for ASCVD and aortic stenosis and influence screening protocols?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Medicaid Work Requirements Set to Leave Millions Without Insurance
3
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
4
Baricitinib Leads to Significant Hair Regrowth in Adolescents With Severe Alopecia Areata
5















































